Basel, Switzerland – Lonza, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, announced today that a planned expansion of its bioconjugation facility in Visp (CH) is complete.
The expansion includes two manufacturing suites and supporting infrastructure. It will support an extended customer portfolio, including companies entering clinical development. The investment enhances Lonza’s capabilities and flexibility to support both clinical and commercial supply and will play a key role in meeting the growing market demand for bioconjugates.
The new suites complement Lonza’s recent investments and asset extensions in Visp (CH) in mammalian capacity, microbial development, drug product development and manufacturing, and HPAPI payload-linker manufacturing capacity. These continued investments into the Visp (CH) site provide a flexible solution for customers of all sizes at a single location. They are designed to help customers navigate the risks of a complex bioconjugation supply chain. In addition to the two new manufacturing suites, the expansion also includes an increase in process and analytical development and quality control capacity to support future portfolio growth.
Stefan Egli, Vice President, Head of Bioconjugates, Lonza, commented: “The opening of the new bioconjugate manufacturing suites in Visp (CH) reflects our dedication to continuously improving our offering and expertise in line with anticipated market and customer needs. Combined with our offerings across drug substance and drug product manufacturing in small molecules and biologics, our bioconjugation services can support projects from early phase through to late-stage and commercial programs.”
As the leading CDMO for bioconjugates, Lonza offers customers a fully integrated solution, including the different technologies required to deliver safe and reliable bioconjugate products.
Galp has taken the final Investment Decision on Green Hydrogen and HVO/SAF projects at its Sines refinery, Portugal
The projects include a 270 ktpa advanced biofuels unit, in partnership with Mitsui, and 100 MW of electrolysers for the production of green hydrogen. Both units are expected to have its first start...
Circular Economy: TotalEnergies to Build a New Plastic Recycling Unit at the Grandpuits Zero-Crude Platform, France
The new unit should enter service in 2026 and produce 30,000 tons a year of high value-added compounds containing up to 50% recycled plastic material.
Air Liquide takes a further step in developing the hydrogen sector at Port-Jérôme, France
investment of over 400 million euros to build its Normand’Hy electrolyzer to contribute to the decarbonization of the Normandy industrial basin and mobility signature of an agreement with TotalEner...
Vertimass EMEA Signs Agreement to Acquire European Renewable Fuel Company Ekobenz in Kleszczów, Poland
The acquisition will bring together companies with complementary technological capabilities, an existing production plant and customer relationships, making Vertimass one of the leading renewable f...